Homepage Natura One, Pty Ltd newsroom

New Supplement to Reduce Chronic Inflammation

Announcement posted by Natura One, Pty Ltd 02 Jul 2018

Emulin® launching soon in Australia

Emulin® is a new supplement that reduces the body's chronic inflammation, resulting in improved energy, chronic pain reduction and weight loss. It is set to launch in Australia in late July 2018.

Created by two-time Nobel Nominee, Joseph Ahrens (a physiologist) and Daryl Thompson (a biochemist), Emulin® acts on all seven key points of carbohydrate metabolism in the body. 

The ingredients are chlorogenic acid from green coffee bean extract, myricetin from grape skin, and quercetin from onion. The scientists worked through hundreds of natural ingredients in varying proportions in order to find the combination with the most powerful effect on carb metabolism.

Clinical studies have shown that Emulin® can remove excess carbohydrates from the body during digestion, thereby improving the body's natural energy regulation, minimizing the storage of caloric intake as fat, moderating energy slumps, reducing chronic pain from inflammation, and resulting in sustained weight loss.

In fact, this supplement has been devised with carb-sensitive people in mind. If you are someone who feels sluggish after a carb-heavy meal, or you would like to lose weight quickly, or reduce chronic pain, this supplement is an effective complementary addition to a well-balanced diet. 

As the scientist behind the supplement, Joseph Ahrens, said: “Emulin® will work even better when used in conjunction with a low carbohydrate diet. This a vital part of our food supply. It has been stripped off by modern agricultural practices and food processing. We need to add this back as we take too much carbohydrates, especially of the refined type. If this compound had been discovered 50 years ago, it would have been classified as a vitamin.”

Emulin® is currently distributed by network marketing company iGalen, Already launched in the United States and Canada (2017), within the first six months of live distribution, iGalen recorded sales of approximately US$2.7 million (AU$3.4 million).

For FAQs, research reports, and to learn how to purchase or distribute Emulin® in Australia, visit https://buyemulinaustralia.com